Daniela T. Furuya
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Palmitate-induced Slc2a4/GLUT4 downregulation in L6 muscle cells: evidence of inflammatory and endoplasmic reticulum stress involvement.
Journal: Lipids in health and disease
Published: June 06, 2017
Reduced Slc2a4/GLUT4 expression in subcutaneous adipose tissue of monosodium glutamate obese mice is recovered after atorvastatin treatment.
Journal: Diabetology & metabolic syndrome
Published: October 14, 2014
Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells.
Journal: Molecular and cellular endocrinology
Published: August 09, 2014
Identification of nuclear factor-κB sites in the Slc2a4 gene promoter.
Journal: Molecular and cellular endocrinology
Published: October 31, 2012
Estrogen receptor 1 agonist PPT stimulates Slc2a4 gene expression and improves insulin-induced glucose uptake in adipocytes.
Journal: Current topics in medicinal chemistry
Published: June 28, 2012
Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-κB and sterol regulatory element-binding protein-1 in adipocytes.
Journal: Journal of molecular endocrinology
Published: June 28, 2012
Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Journal: Metabolism: clinical and experimental
Published: January 14, 2009
Showing 1-8 of 8
Last Updated: 09/26/2026